Arrowhead Research Corporation - symbol ARWR - reported the publication of data in the Science Translational Medicine from its majority-owned subsidiary Ablaris Therapeutics’ lead drug candidate, Adipotid, demonstrating weight loss and reduction in body mass index and abdominal circumference in obese rhesus monkeys
